Who Can Afford Gilead’s US$1,000 Pill Daily?

SEOUL, Sept. 18 (Korea Bizwire) – As Sovaldi, a new drug for the hepatitis C virus developed by US-based biotechnology company Gilead, has been approved by the Ministry of Food and Drug Safety of Korea, speculation is mounting over how much it will cost in Korea. The drug is currently being sold for US$1,000 a pill [...]